Nippon Steel Says It Could Issue Equity to Fund US Takeover

Nippon Steel Corp. could issue equity to fund its $14.1 billion purchase of United States Steel Corp. and associated investment promises, the company's vice chairman said on Thursday.
'We aren't ruling out equity to fund the investment in US Steel,' Takahiro Mori told reporters in Tokyo. He added that the company would seek to avoid options that could dilute existing shareholders, but gave no further details.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Yahoo

an hour ago

• Yahoo

Johan Holdings Berhad Third Quarter 2025 Earnings: EPS: RM0.007 (vs RM0.008 loss in 3Q 2024)

Net income: RM8.15m (up from RM8.78m loss in 3Q 2024). EPS: RM0.007 (up from RM0.008 loss in 3Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period Johan Holdings Berhad shares are up 20% from a week ago. You should always think about risks. Case in point, we've spotted 3 warning signs for Johan Holdings Berhad you should be aware of, and 2 of them are concerning. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Yahoo

an hour ago

• Yahoo

Visdynamics Holdings Berhad Second Quarter 2025 Earnings: EPS: RM0.004 (vs RM0.005 loss in 2Q 2024)

Revenue: RM7.85m (up 315% from 2Q 2024). Net income: RM954.0k (up from RM1.41m loss in 2Q 2024). Profit margin: 12% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. EPS: RM0.004 (up from RM0.005 loss in 2Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period Visdynamics Holdings Berhad shares are up 5.1% from a week ago. You should learn about the 4 warning signs we've spotted with Visdynamics Holdings Berhad (including 2 which don't sit too well with us). Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Yahoo

an hour ago

• Yahoo

Investors in IHH Healthcare Berhad (KLSE:IHH) have seen notable returns of 38% over the past five years

When we invest, we're generally looking for stocks that outperform the market average. And in our experience, buying the right stocks can give your wealth a significant boost. For example, the IHH Healthcare Berhad (KLSE:IHH) share price is up 28% in the last 5 years, clearly besting the market return of around 6.4% (ignoring dividends). On the other hand, the more recent gains haven't been so impressive, with shareholders gaining just 12%, including dividends. So let's assess the underlying fundamentals over the last 5 years and see if they've moved in lock-step with shareholder returns. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time. Over half a decade, IHH Healthcare Berhad managed to grow its earnings per share at 114% a year. The EPS growth is more impressive than the yearly share price gain of 5% over the same period. So it seems the market isn't so enthusiastic about the stock these days. You can see below how EPS has changed over time (discover the exact values by clicking on the image). Dive deeper into IHH Healthcare Berhad's key metrics by checking this interactive graph of IHH Healthcare Berhad's earnings, revenue and cash flow. As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. We note that for IHH Healthcare Berhad the TSR over the last 5 years was 38%, which is better than the share price return mentioned above. This is largely a result of its dividend payments! It's good to see that IHH Healthcare Berhad has rewarded shareholders with a total shareholder return of 12% in the last twelve months. That's including the dividend. Since the one-year TSR is better than the five-year TSR (the latter coming in at 7% per year), it would seem that the stock's performance has improved in recent times. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. Before forming an opinion on IHH Healthcare Berhad you might want to consider these 3 valuation metrics. If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: many of them are unnoticed AND have attractive valuation). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Malaysian exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data